1. Home
  2. NAII vs AIMD Comparison

NAII vs AIMD Comparison

Compare NAII & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

HOLD

Current Price

$2.51

Market Cap

16.8M

Sector

Health Care

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$2.10

Market Cap

17.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAII
AIMD
Founded
1980
1984
Country
United States
United States
Employees
N/A
41
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.8M
17.5M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
NAII
AIMD
Price
$2.51
$2.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.5K
865.8K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$132,437,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.60
N/A
52 Week Low
$2.33
$0.45
52 Week High
$4.96
$4.50

Technical Indicators

Market Signals
Indicator
NAII
AIMD
Relative Strength Index (RSI) 38.24 52.86
Support Level $2.40 $1.55
Resistance Level $2.86 $2.51
Average True Range (ATR) 0.13 0.44
MACD -0.01 0.04
Stochastic Oscillator 19.51 27.53

Price Performance

Historical Comparison
NAII
AIMD

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: